Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production

The FDA has given the regulatory thumbs-up in the US of Reblozyl (luspatercept-aamt), the “first and only erythroid maturation agent” according to...
COVID-19 coronavirus treatments dominate the news as the world looks for a vaccine. Johnson & Johnson announced that it has selected a candidate...
Business ploughs on even in a global crisis; we bring you the latest in pharma, biotech and healthcare, from the news that Big Pharma stands as one...
Axsome Therapeutics reported on Monday that its Phase 3 study of its experimental depression drug missed its main trial goal.

Features

Conor Kavanagh investigates the role state healthcare institutions play in negotiating drug prices, and what steps can be taken for a more...

Appointments

BrainStorm Cell Therapeutics, a firm developing cellular therapies to tackle neurodegenerative diseases, has named industry Big Pharma veteran Dr...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches